PCDIS0W Stock Latest News
Private CompaniesLeadership Recognition Highlights Key Scientist at Dispatch Bio3w agoDIS0W
Private CompaniesDispatch Bio Highlights Platform-Based Immunotherapy Pipeline for Solid Tumors1M agoDIS0W
Private CompaniesDispatch Bio Highlights Tumor-Agnostic Immunotherapy Platform Targeting Solid Cancers2M agoDIS0W
Private CompaniesDispatch Bio Advances DISP-10 With FDA Fast Track and Phase 1 Trial Initiation2M agoDIS0W
Private CompaniesDispatch Bio Targets Advanced GI Cancers With Novel Immunotherapy Platform3M agoDIS0W
Private CompaniesDispatch Bio Highlights Solid Tumor Platforms and Preclinical Progress5M agoDIS0W
Private CompaniesDispatch Bio Highlights Solid Tumor Platforms and New Preclinical Data5M agoDIS0W
Private CompaniesPreclinical T Cell Armoring Data Spotlighted by Dispatch Bio at ASGCT 20265M agoDIS0W
Private CompaniesDispatch Bio Showcases SEND T Cell Armoring Data at ASGCT 20265M agoDIS0WPrivate CompaniesPrecision Oncology Strategy Highlighted by Dispatch Bio’s Flare Platform5M agoDIS0W
Private CompaniesDispatch Bio Highlights Dual-Stage Precision Oncology Platform Strategy5M agoDIS0W
Private CompaniesDispatch Bio Showcases SEND Platform Progress and Leadership Recognition in Busy Week6M agoDIS0W
Private CompaniesDispatch Bio to Present SEND T Cell Armoring Preclinical Data at ASGCT 20266M agoDIS0WPrivate CompaniesDispatch Bio Highlights SEND Platform Ahead of ASGCT 2026 Preclinical Data6M agoDIS0W
Private CompaniesLeadership Recognition Highlights Dispatch Bio’s Profile in Philadelphia Biotech Hub6M agoDIS0W


